Literature DB >> 16014410

Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis.

J S Seo1, S-S Lee, S I Kim, W H Ryu, K H Sa, S U Kim, S W Han, E J Nam, J Y Park, W K Lee, S Y Kim, Y M Kang.   

Abstract

OBJECTIVES: To investigate the role of polymorphisms of the vascular endothelial growth factor (VEGF) gene in susceptibility to ankylosing spondylitis (AS), and their relationship to clinical features and radiographic severity.
METHODS: This study included 157 patients with AS and 140 healthy unrelated controls. Polymorphisms of the VEGF gene were analysed by the polymerase chain reaction (PCR)-restriction fragment length polymorphism assay and amplification refractory mutation system-PCR. Haplotypes were reconstructed using the Bayesian algorithm. Radiographic severity was assessed by the Bath Ankylosing Spondylitis Radiological Index (BASRI).
RESULTS: The genotype frequencies of the polymorphisms were in Hardy-Weinberg equilibrium. The distributions of genotypes and alleles did not differ between AS patients and controls. Among the six haplotypes reconstructed based on the tight linkage disequilibrium at positions -2578, -1154 and -634 (pairwise linkage disequilibrium coefficient, r = 0.361-0.706), no haplotype was associated with susceptibility to AS. Clinical features were analysed for the four haplotypes (CGC, CGG, AAG, AGG) which were prevalent. In carriers of the AGG haplotype, the frequency of cervical spine involvement was significantly higher (P = 0.002, P(corr) = 0.036) and that of patients showing a BASRI score >6 was also higher (P = 0.025, P(corr) = 0.45).
CONCLUSIONS: This study demonstrates that polymorphisms of the VEGF gene may contribute to disease severity in AS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014410     DOI: 10.1093/rheumatology/kei013

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

1.  Power Doppler ultrasonography in the evaluation of infliximab treatment for sacroiliitis in patients with ankylosing spondylitis.

Authors:  Yeqing Jiang; Ling Chen; Jiaan Zhu; Qin Xue; Niansong Wang; Yunxia Huang; Fang Liu; Yizhou Hu; Bing Hu
Journal:  Rheumatol Int       Date:  2013-02-06       Impact factor: 2.631

2.  Changes in gene expression profiles of the hip joint ligament of patients with ankylosing spondylitis revealed by DNA chip.

Authors:  Ling Xu; Qingwen Sun; Songmin Jiang; Jia Li; Chongru He; Weidong Xu
Journal:  Clin Rheumatol       Date:  2012-08-18       Impact factor: 2.980

3.  VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.

Authors:  Paolo Maltese; Emanuele Canestrari; Annamaria Ruzzo; Francesco Graziano; Alfredo Falcone; Fotios Loupakis; Giuseppe Tonini; Daniele Santini; Mauro Magnani
Journal:  Int J Colorectal Dis       Date:  2008-10-02       Impact factor: 2.571

4.  Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.

Authors:  J Bhaskari; C S Premalata; V Shilpa; B Rahul; V R Pallavi; G Ramesh; Lakshmi Krishnamoorthy
Journal:  Tumour Biol       Date:  2015-08-13

5.  VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis.

Authors:  Christopher Butt; Sooyeol Lim; Celia Greenwood; Proton Rahman
Journal:  BMC Musculoskelet Disord       Date:  2007-01-04       Impact factor: 2.362

6.  Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.

Authors:  Bhaskari Janardhan; Shilpa Vaderhobli; Rahul Bhagat; Premalata Chennagiri Srinivasamurthy; Pallavi Venketeshiah Reddihalli; Ramesh Gawari; Lakshmi Krishnamoorthy
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

7.  Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis.

Authors:  Young Bin Joo; So-Young Bang; Tae-Hwan Kim; Seung-Cheol Shim; Seunghun Lee; Kyung Bin Joo; Jong Heon Kim; Hye Joon Min; Proton Rahman; Robert D Inman
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

Review 8.  Vascular endothelial growth factor (VEGF) in autoimmune diseases.

Authors:  Jozélio Freire Carvalho; Miri Blank; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2007-03-06       Impact factor: 8.542

9.  Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.

Authors:  S Visvanathan; C Wagner; J C Marini; D Baker; T Gathany; J Han; D van der Heijde; J Braun
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.